The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice

Minimal residual disease (MRD) in non-Hodgkin's lymphomas (NHLs) still represents matter of interest and debate: indeed, the new available treatments offer higher rates of complete responses and MRD negativity than in the past, with a positive impact on the long-term survival. Furthermore, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Galimberti, Sara, Genuardi, Elisa, Mazziotta, Francesco, Iovino, Lorenzo, Morabito, Fortunato, Grassi, Susanna, Ciabatti, Elena, Guerrini, Francesca, Petrini, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606710/
https://www.ncbi.nlm.nih.gov/pubmed/31293969
http://dx.doi.org/10.3389/fonc.2019.00528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606710/
https://www.ncbi.nlm.nih.gov/pubmed/31293969
http://dx.doi.org/10.3389/fonc.2019.00528

Ejemplares similares